Researchers are developing novel therapies, diagnostics and biomarkers in the fight against infectious tropical diseases that affect millions of people worldwide, primarily those living in poverty.
In this podcast, Peter Madrid, a program director in SRI's Biosciences Division, discusses the latest SRI research on a new drug target that may potentially reduce infectious disease treatment time.
